CY1106656T1 - Χρηση ελαστασης για διανοιξη αποφραγμενων αρτηριων και φλεβων - Google Patents
Χρηση ελαστασης για διανοιξη αποφραγμενων αρτηριων και φλεβωνInfo
- Publication number
- CY1106656T1 CY1106656T1 CY20071100790T CY071100790T CY1106656T1 CY 1106656 T1 CY1106656 T1 CY 1106656T1 CY 20071100790 T CY20071100790 T CY 20071100790T CY 071100790 T CY071100790 T CY 071100790T CY 1106656 T1 CY1106656 T1 CY 1106656T1
- Authority
- CY
- Cyprus
- Prior art keywords
- circuit
- blockage
- clocked
- arteries
- veins
- Prior art date
Links
- 210000001367 artery Anatomy 0.000 title 1
- 210000003462 vein Anatomy 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 abstract 3
- 108090000790 Enzymes Proteins 0.000 abstract 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 210000002744 extracellular matrix Anatomy 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/486—Elastase (3.4.21.36 or 3.4.21.37)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
- Enzymes And Modification Thereof (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Materials For Medical Uses (AREA)
- Processing Of Meat And Fish (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η εφεύρεση παρέχει μεθόδους θεραπείας ενός αποφραγμένου βιολογικού κυκλώματος, που περιλαμβάνει χορήγηση στο κύκλωμα ενός παράγοντα ο οποίος αποικοδομεί κυτταρική μήτρα αποφραγμένου ιστού. Ιδιαίτερες μέθοδοι περιλαμβάνουν απελευθέρωση ενός ενζύμου ή μίγματος διαφόρων ενζύμων στην περιοχή ή στο μέρος του σώματος της απόφραξης, όπου το ένζυμο (ένζυμα) έχει την ικανότητα να αποικοδομεί συστατικά εξωκυτταρικής μήτρας εντός της απόφραξης, επανορθώνοντας έτσι την κανονική ροή μεταφερόμενου υγρού μέσω του κυκλώματος. Η εφεύρεση επίσης περιλαμβάνει προληπτικώς διαστολή ενός τμήματος κυκλώματος για να ελαχιστοποιείται ο κίνδυνος σχηματισμού απόφραξης.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15593899P | 1999-09-24 | 1999-09-24 | |
PCT/US2000/026237 WO2001021574A1 (en) | 1999-09-24 | 2000-09-24 | Systems and methods for opening obstructed biological conduits |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1106656T1 true CY1106656T1 (el) | 2012-01-25 |
Family
ID=22557384
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20071100790T CY1106656T1 (el) | 1999-09-24 | 2007-06-14 | Χρηση ελαστασης για διανοιξη αποφραγμενων αρτηριων και φλεβων |
CY20111100865T CY1112329T1 (el) | 1999-09-24 | 2011-09-08 | Συστηματα και μεθοδοι για διανοιξη αποφραγμενων βιολογικων αγωγων |
CY20151100477T CY1117932T1 (el) | 1999-09-24 | 2015-05-29 | Ελασταση για διανοιξη αποφραγμενων βιολογικων διαυλων |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20111100865T CY1112329T1 (el) | 1999-09-24 | 2011-09-08 | Συστηματα και μεθοδοι για διανοιξη αποφραγμενων βιολογικων αγωγων |
CY20151100477T CY1117932T1 (el) | 1999-09-24 | 2015-05-29 | Ελασταση για διανοιξη αποφραγμενων βιολογικων διαυλων |
Country Status (12)
Country | Link |
---|---|
EP (4) | EP2363142B8 (el) |
JP (2) | JP5763286B2 (el) |
AT (2) | ATE361095T1 (el) |
AU (1) | AU7612100A (el) |
CA (1) | CA2385488C (el) |
CY (3) | CY1106656T1 (el) |
DE (1) | DE60034694T2 (el) |
DK (3) | DK1923068T3 (el) |
ES (3) | ES2284528T3 (el) |
HK (1) | HK1162302A1 (el) |
PT (3) | PT1923068E (el) |
WO (1) | WO2001021574A1 (el) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7063838B1 (en) | 1999-09-24 | 2006-06-20 | Proteon Therapeutics Llc | Methods for treating an artery or vein in a human subject |
AU2004213050B2 (en) | 2003-02-20 | 2010-09-09 | Proteon Therapeutics, Inc. | Methods for the treatment and prevention of diseases of biological conduits |
WO2006036804A2 (en) * | 2004-09-22 | 2006-04-06 | Proteon Therapeutics, Inc. | Methods for the treatment and prevention of diseases of biological conduits |
US10071143B1 (en) | 2007-05-03 | 2018-09-11 | The Research Foundation For The State University Of New York | Methods for non-surgical treatment of carpal tunnel syndrome |
US8501449B2 (en) * | 2007-12-04 | 2013-08-06 | Proteon Therapeutics, Inc. | Recombinant elastase proteins and methods of manufacturing and use thereof |
ES2740499T3 (es) | 2012-01-12 | 2020-02-05 | Endo Global Ventures | Enzima de Clostridium histolyticum |
US9636385B2 (en) | 2012-10-24 | 2017-05-02 | The Research Foundation For The State University Of New York | Use of collagenase to treat glaucoma |
EP3589204A1 (en) | 2017-03-01 | 2020-01-08 | Endo Ventures Limited | Apparatus and method for assessing and treating cellulite |
AU2018244426A1 (en) | 2017-03-28 | 2019-10-17 | Endo Ventures Limited | Improved method of producing collagenase |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5489261A (en) * | 1981-01-26 | 1996-02-06 | Trustees Of Boston University | Hydrogels capable of supporting cell growth |
US4636195A (en) * | 1982-04-02 | 1987-01-13 | Harvey Wolinsky | Method and apparatus for removing arterial constriction |
US4803294A (en) * | 1987-10-29 | 1989-02-07 | G. D. Searle & Co. | Process and intermediates for the preparation of halogenated protease inhibitors |
JPH0286777A (ja) * | 1988-09-22 | 1990-03-27 | Sankyo Co Ltd | サル膵臓エラスターゼi |
US5116615A (en) * | 1989-01-27 | 1992-05-26 | Immunolytics, Inc. | Method for treating benign prostatic hypertrophy |
DK0456724T3 (da) * | 1989-01-27 | 1995-10-02 | Immunolytics Inc | Præparat og fremgangsmåde til behandling af benign prostatisk hypertrofi |
US5328470A (en) * | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
NL8900943A (nl) * | 1989-04-14 | 1990-11-01 | Euro Biopharm Technology B V | Protease inhibitor. |
US5318531A (en) * | 1991-06-11 | 1994-06-07 | Cordis Corporation | Infusion balloon catheter |
US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5422261A (en) * | 1993-04-16 | 1995-06-06 | Baxter International Inc. | Composition containing collagenase and chymopapain for hydrolyzing connective tissue to isolate cells |
US5409926A (en) | 1993-07-19 | 1995-04-25 | Merck & Co., Inc. | AT-2 antagonist inhibition of vascular restenosis |
EP0815202B1 (en) * | 1994-12-13 | 2007-02-21 | Human Genome Sciences, Inc. | Human tissue inhibitor of metalloproteinase-4 |
US6020181A (en) * | 1995-05-17 | 2000-02-01 | New York Blood, Inc. | Inhibition of thrombus formation by medical related apparatus comprising treating with fibrinolytic matrix metalloproteinase |
US5830468A (en) * | 1995-05-17 | 1998-11-03 | The New York Blood Center, Inc. | Fibrin(ogen) degradation by fibrinolytic matrix metalloproteinase |
US5834449A (en) * | 1996-06-13 | 1998-11-10 | The Research Foundation Of State University Of New York | Treatment of aortic and vascular aneurysms with tetracycline compounds |
ZA98376B (en) * | 1997-01-23 | 1998-07-23 | Hoffmann La Roche | Sulfamide-metalloprotease inhibitors |
-
2000
- 2000-09-24 ES ES00965396T patent/ES2284528T3/es not_active Expired - Lifetime
- 2000-09-24 ES ES10180533.1T patent/ES2534938T3/es not_active Expired - Lifetime
- 2000-09-24 DK DK07008805T patent/DK1923068T3/da active
- 2000-09-24 DK DK10180533T patent/DK2363142T3/en active
- 2000-09-24 EP EP10180533.1A patent/EP2363142B8/en not_active Expired - Lifetime
- 2000-09-24 PT PT07008805T patent/PT1923068E/pt unknown
- 2000-09-24 EP EP20070008805 patent/EP1923068B1/en not_active Expired - Lifetime
- 2000-09-24 CA CA2385488A patent/CA2385488C/en not_active Expired - Fee Related
- 2000-09-24 DE DE2000634694 patent/DE60034694T2/de not_active Expired - Lifetime
- 2000-09-24 DK DK00965396T patent/DK1220830T3/da active
- 2000-09-24 WO PCT/US2000/026237 patent/WO2001021574A1/en active IP Right Grant
- 2000-09-24 JP JP2001524955A patent/JP5763286B2/ja not_active Expired - Fee Related
- 2000-09-24 AT AT00965396T patent/ATE361095T1/de active
- 2000-09-24 EP EP20100183002 patent/EP2332568A1/en not_active Withdrawn
- 2000-09-24 PT PT101805331T patent/PT2363142E/pt unknown
- 2000-09-24 AU AU76121/00A patent/AU7612100A/en not_active Abandoned
- 2000-09-24 AT AT07008805T patent/ATE511854T1/de active
- 2000-09-24 PT PT00965396T patent/PT1220830E/pt unknown
- 2000-09-24 EP EP20000965396 patent/EP1220830B1/en not_active Expired - Lifetime
- 2000-09-24 ES ES07008805T patent/ES2364191T3/es not_active Expired - Lifetime
-
2007
- 2007-06-14 CY CY20071100790T patent/CY1106656T1/el unknown
-
2011
- 2011-09-08 CY CY20111100865T patent/CY1112329T1/el unknown
-
2012
- 2012-03-07 HK HK12102287.4A patent/HK1162302A1/xx not_active IP Right Cessation
- 2012-04-04 JP JP2012085454A patent/JP5793461B2/ja not_active Expired - Fee Related
-
2015
- 2015-05-29 CY CY20151100477T patent/CY1117932T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106656T1 (el) | Χρηση ελαστασης για διανοιξη αποφραγμενων αρτηριων και φλεβων | |
TR200201440T2 (tr) | Biomedikal kullanım için radyum-223 hazırlanması | |
DK0717635T3 (da) | Fremgangsmåder til reduktion af gastrointestinal motilitet | |
BR9812965A (pt) | Métodos para tratamento de estados hipercoaguláveis ou deficiência de proteìna c adquirida | |
FI932789A0 (fi) | Emättimensisäinen antosysteemi | |
DK1028707T3 (da) | Oftalmiske præparater med forlænget frigivelse og indeholdende vandopløselige medikamenter | |
CY1107752T1 (el) | Xρηση των εξενδινων και αγωνιστων τους για τη θεραπεια του σακχαρωδους διαβητη της κυησης | |
BR0308090A (pt) | conjugados de agentes citotóxicos ou terapêuticos e peptìdios biologicamente ativos | |
DE69535752D1 (de) | Alpha(1,3)galactosyltransferase-negatives schwein | |
TR200102308T2 (tr) | Yüzey etkinliğine sahip yapay peptidler ve bunların yapay yüzey aktif maddelerin hazırlanmasında kullanımı | |
BR0210335A (pt) | Copolìmero de blocos, e, composição | |
WO2000018331A3 (en) | Drug delivery systems | |
EA200300560A1 (ru) | Улучшенный способ лечения | |
BR0010314A (pt) | Solução aquosa de conservação de tecidos e órgãos | |
AU3527700A (en) | Foam control agents for silicone surfactants | |
SE0004710L (sv) | System och förfarande | |
DE69120287T2 (de) | Aminosulfonylharnstoff-acat-inhibitoren | |
DK0637327T3 (da) | Polyetheramidoaminhydrogeler som hepariniserbare materialer | |
TR200400424T4 (tr) | IOP'nin kontrolü ve glokom tedavisi için 5HT2 agonistleri | |
EP1222854A4 (en) | PREVENTION AND TREATMENT OF DISEASES ASSOCIATED WITH BLOOD COAGULATION | |
MX9805939A (es) | Formas solidas de administracion, de liberacion instantanea y procesos para su produccion. | |
DK0821593T3 (da) | Konjugat af et aktivt middel, et protein og eventuelt et for kroppen ikke som fremmed anset nativt protein | |
ATE323513T1 (de) | Desinfektionsmittel für absauganlagen im medizinischen bereich | |
ES2103482T3 (es) | Antigeno de linfocitos t citotoxicos utilizado como inhibidor de la cisteina proteasa. | |
DE69930419D1 (de) | Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie |